ETF Managers Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $5.96M | Buy |
18,918
+16,194
| +594% | +$5.1M | 0.19% | 95 |
|
|
2022
Q4 | $787K | Sell |
2,724
-2,847
| -51% | -$822K | 0.04% | 193 |
|
|
2022
Q3 | $1.61M | Sell |
5,571
-663
| -11% | -$192K | 0.05% | 168 |
|
|
2022
Q2 | $1.75M | Buy |
6,234
+3,000
| +93% | +$841K | 0.05% | 176 |
|
|
2022
Q1 | $830K | Buy |
3,234
+56
| +2% | +$14.4K | 0.02% | 334 |
|
|
2021
Q4 | $707K | Buy |
3,178
+150
| +5% | +$33.4K | 0.01% | 429 |
|
|
2021
Q3 | $552K | Buy |
3,028
+234
| +8% | +$42.7K | 0.01% | 512 |
|
|
2021
Q2 | $550K | Buy |
2,794
+1,455
| +109% | +$286K | 0.01% | 522 |
|
|
2021
Q1 | $285K | Buy |
1,339
+175
| +15% | +$37.2K | 0.01% | 593 |
|
|
2020
Q4 | $271K | Sell |
1,164
-1,457
| -56% | -$339K | 0.01% | 560 |
|
|
2020
Q3 | $708K | Sell |
2,621
-1,092
| -29% | -$295K | 0.02% | 252 |
|
|
2020
Q2 | $1.06M | Buy |
+3,713
| New | +$1.06M | 0.04% | 174 |
|
|
2019
Q2 | – | Sell |
-877
| Closed | -$161K | – | 661 |
|
|
2019
Q1 | $161K | Buy |
877
+73
| +9% | +$13.4K | 0.01% | 368 |
|
|
2018
Q4 | $133K | Buy |
804
+120
| +18% | +$19.9K | 0.01% | 371 |
|
|
2018
Q3 | $132K | Buy |
684
+72
| +12% | +$13.9K | 0.01% | 338 |
|
|
2018
Q2 | $72 | Sell |
612
-30
| -5% | -$4 | 0.01% | 341 |
|
|
2018
Q1 | $100K | Buy |
642
+80
| +14% | +$12.5K | 0.01% | 282 |
|
|
2017
Q4 | $86K | Buy |
562
+80
| +17% | +$12.2K | 0.01% | 263 |
|
|
2017
Q3 | $73K | Buy |
482
+40
| +9% | +$6.06K | 0.01% | 158 |
|
|
2017
Q2 | $57K | Buy |
+442
| New | +$57K | ﹤0.01% | 235 |
|
|
2016
Q1 | $33K | Buy |
+298
| New | +$33K | 0.02% | 277 |
|